Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 5,070Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20251013112813/en/Tvardi-Therapeutics-Provides-Update-on-Preliminary-Data-from-Phase-2-REVERT-Trial-in-Idiopathic-Pulmonary-Fibrosis

BUSINESSWIRE
13 Oct 2025